Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer is a research paper published in World Journal of Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA250412
NCI NIH HHS
Grant: P30 CA016056
NIBIB NIH HHS
Grant: R01 EB029596
NCI NIH HHS
Grant: R01 CA251545
NCI NIH HHS
Grant: R37 CA248018
National Institutes of Health
Grant: 5R01CA251545-02
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
National Institutes of Health
Grant: 5R01EB029596-03
Multiparametric photoacoustic and ultrasonic imaging of the breast in cranial-caudal view
National Institutes of Health
Grant: 5R37CA248018-04
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA250412-02
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
Fields of Study
Keywords